Skip to main content
Equibles
NHC logo

NHC · National Healthcare Corp · Metrics

Track NHC — free

Use NHC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NHC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$236.01 -7.06 (-2.90%) At close · Oct 23
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$3.70B
Shares
15.66M
Volume · Oct 23 192.99K Avg daily vol (3M) 109.17K

NHC metrics

111 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$236.01
Market cap
$3.70B

Price action

20 metrics
Price change (1W)
-2.8%
Price change (30D)
+3.8%
Price change (3M)
+4.6%
Price change (6M)
+36.5%
Price change (YTD)
+72.2%
Price change (1Y)
+93.3%
Trailing year
Price change (5Y)
+231.4%
52-week high
$247.94
52-week low
$119.44
Change from 52-week high
-4.8%
Change from 52-week low
+97.6%
Annualized volatility
34.1%
Annualized volatility (3M)
34.1%
Beta
0.2
RSI (14D)
53.0
Price vs SMA 50
+3.6%
Price vs SMA 200
+22.9%
Avg volume (3M)
109,174
Relative volume
1.8
Average dollar volume
$24.73M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
15.66M

Valuation

12 metrics
P / E (TTM)
26.5
Trailing earnings · reciprocal yield 3.8%
PEG ratio
0.4
EV / revenue
2.3×
reciprocal yield 42.6%
EV / EBITDA
19.2×
reciprocal yield 5.2%
EV / EBIT
25.3×
reciprocal yield 4.0%
P / sales
2.4×
reciprocal yield 42.2%
P / book
3.3
reciprocal yield 30.4%
FCF yield
4.0%
TTM · current market cap
Buyback yield
0.9%
P / FCF
25.2
reciprocal yield 4.0%
P / operating cash flow
19.6
reciprocal yield 5.1%
Earnings yield
3.8%

Historical valuation

8 metrics
P / E historical average (3Y)
19.1×
reciprocal yield 5.2%
P / E historical average (5Y)
21.5×
reciprocal yield 4.7%
EV / revenue historical average (3Y)
1.5×
reciprocal yield 68.6%
EV / revenue historical average (5Y)
1.5×
reciprocal yield 68.6%
EV / EBIT historical average (3Y)
18.7×
reciprocal yield 5.3%
EV / EBIT historical average (5Y)
18.7×
reciprocal yield 5.3%
EV / EBITDA historical average (3Y)
13.4×
reciprocal yield 7.5%
EV / EBITDA historical average (5Y)
13.4×
reciprocal yield 7.5%

Dividends & buybacks

7 metrics
Dividend yield
1.1%
Trailing 12 months
Payout ratio
28.4%
Shareholder yield
1.9%
Dividend / share (TTM)
$2.62
Dividend growth YoY
+4.8%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-09-30

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
9.3%
Trailing 12 months
Net margin
9.0%
Gross profit (TTM)
—
Operating profit (TTM)
$144.68M
Net income (TTM)
$140.18M
Trailing 12 months
Diluted EPS (TTM)
$8.89
FCF margin
9.4%
Effective tax rate
22.9%

Per share

11 metrics
Revenue per diluted share (TTM)
$98.91
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$9.17
EBITDA per diluted share (TTM)
$12.07
Net income per diluted share (TTM)
$8.89
Operating cash flow per diluted share (TTM)
$11.99
Free cash flow per diluted share (TTM)
$9.31
Capital expenditures per diluted share (TTM)
$2.68
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.34
Book value per share
$68.79

Growth

11 metrics
Revenue growth YoY
+8.8%
Year over year
Net income growth YoY
+70.0%
Revenue (TTM)
$1.56B
Trailing 12 months
EPS growth YoY
+67.1%
Shares change YoY
+1.7%
Year over year · more shares
Revenue CAGR (3Y)
+11.8%
Revenue CAGR (5Y)
+8.1%
EPS CAGR (3Y)
+74.2%
EPS CAGR (5Y)
+23.0%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-3.9%

Quality

14 metrics
Return on equity
12.5%
Return on assets
9.1%
Debt / equity
0.0
Current ratio
1.9
EBITDA (TTM)
$190.40M
Free cash flow (TTM)
$146.53M
Quick ratio
1.8
Interest coverage
56.6
Net debt / EBITDA
-0.2
Return on invested capital
10.3%
Trailing 12 months
Net cash
$39.21M
Latest balance sheet
Cash & equivalents
$39.21M
Total assets
$1.54B
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$188.81M
Capital expenditures (TTM)
$42.27M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$5.41M
R&D / revenue
—
Stock compensation / revenue
0.3%

Ownership (13F)

9 metrics
13F filers
252
13F filer change QoQ
+12
Institutional ownership
65.4%
Conviction holders (share of 13F filers)
0.8%
Crowding (high-turnover and private-fund holders)
17.0%
Private-fund adviser ownership
16.8%
Active holders' share change QoQ
-3.5%
Holder tenure
13.4
Price vs estimated holder cost
+62.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
29.7%

Short interest

3 metrics
Short interest
5.2%
Latest settlement · 6.2 days to cover
Days to cover
6.2d
Short-squeeze score
69 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$5.58M
Insider-sentiment score
9 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1047335 CUSIP 635906100 13F (30d) 51 filings 51 filers Visit website Investor relations